10Z-Nonadecenoic acid
CAS No. 73033-09-7
10Z-Nonadecenoic acid( —— )
Catalog No. M21426 CAS No. 73033-09-7
10Z-Nonadecenoic acid is a kind of long-chain fatty acid with anti-tumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 41 | Get Quote |
|
| 10MG | 56 | Get Quote |
|
| 25MG | 89 | Get Quote |
|
| 50MG | 127 | Get Quote |
|
| 100MG | 182 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name10Z-Nonadecenoic acid
-
NoteResearch use only, not for human use.
-
Brief Description10Z-Nonadecenoic acid is a kind of long-chain fatty acid with anti-tumor activity.
-
Description10Z-Nonadecenoic acid is a kind of long-chain fatty acid with anti-tumor activity.
-
In Vitro10Z-Nonadecenoic acid is a kind of long-chain fatty acid with anti-tumor activity. 10Z-Nonadecenoic acid could also inhibit p53 activity.
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number73033-09-7
-
Formula Weight296.49
-
Molecular FormulaC19H36O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:30mg/ml(101.18mM)
-
SMILESCCCCCCCC/C=C\CCCCCCCCC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fukuzawa M1 et al. Possible involvement of long chain fatty acids in the spores of Ganoderma lucidum (Reishi Houshi) to its anti-tumor activity. Biol Pharm Bull. 2008 Oct;31(10):1933-7.
molnova catalog
related products
-
Pyridoxylamine
Pyridoxylamine is an inhibitor of advanced glycation end production (AGEs) and lipoxidation end products (ALEs).
-
1-Methyl-6-oxo-16-di...
1-Methyl-6-oxo-16-dihydropyridine-3-carboxamide is one of the end degradation products of nicotinamide-adenine dinucleotide (NAD).
-
Murideoxycholic Acid
Murideoxycholic Acid alleviates non-alcoholic fatty liver disease by modulating the enterohepatic axis.
Cart
sales@molnova.com